Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 16

Apparel Pharmaceuticals Finance Licensing 16

Harvard Business Review

AUGUST 8, 2018

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. In another supplementary analysis, we used the rankings of finance departments in business schools.

Influence 15

Influence Education Pharmaceuticals Finance 15

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Information & technology Operations Organizational culture Product development'

Productivity 10

Productivity Products Company Engineering 10

Harvard Business Review

OCTOBER 25, 2018

The superstars tend to be more involved in global flows of trade and finance, more digitally mature, and they dominate the lists of the most valued companies, the most valued brands, the most desirable places to work, and the most innovative companies. The link between superstar firms, sectors, and cities is complex.

Industry 15

Industry Company GDP Bottom-up 15

Harvard Business Review

NOVEMBER 10, 2017

In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy. Every organization has functions that wield a disproportionate amount of power — the typical suspects are finance, procurement, and audit. Insight center.

Skills 15

Skills Agility Learning-by-Doing Content 15

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Aside from reducing the use of low-value services, one potential solution is to identify and develop sources of long term financing for high-value services.

Health Care 9

Health Care Insurance Pharmaceuticals Incentives 9

Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

FEBRUARY 4, 2013

Perhaps surprisingly, two leading examples come from pharmaceutical companies. We're moving towards innovation in technology, pricing, business models and partnerships," explains head of corporate responsibility management, Dorje Mundle, of the company's base-of-the-pyramid operations. Breakthrough Finance. Breakthrough Access.

EPS 9

EPS Innovation CEO Pharmaceuticals 9

Harvard Business Review

OCTOBER 24, 2013

Between October 1 and 17, the federal government ceased all nonessential operations because of a partisan stalemate over Obamacare. Although it is premature to declare this the greatest example of misgovernance in modern U.S. Congressional history, this impasse ranks highly. Fast track review of new “breakthrough” drugs stalled.

Health Care 9

Health Care Budgeting Pharmaceuticals Review 9

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Each of the potential business benefits of 3D printing carries tax implications that could alter the equation for any anticipated operating efficiency or return on investment. Are there operations you would shed?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

MAY 15, 2013

Organizational culture is shaped by and overlaps with other cultures — especially the broader culture of the societies in which it operates. finance vs. marketing) and units (e.g. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm).

Incentives 9

Incentives Definition Pharmaceuticals System 9

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. It is a simple, clear, and highly useful criterion — for routine decisions in businesses operating in competitive markets and with sound legal systems. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. True, some of these are low-paying, burger-flipper jobs.

Intellectual Capital 9

Intellectual Capital Magazine Pharmaceuticals Creativity 9

Harvard Business Review

FEBRUARY 24, 2015

The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

MAY 5, 2016

sanctions are delaying these projects being financed. And alongside the country’s bad debt (some estimates say it is $40 billion ), sanctions were commonly evaded through money laundering , which discouraged foreign banks from operating locally. However, remaining U.S. financial system for bank transactions related to Iran.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Marshall Goldsmith

FEBRUARY 8, 2018

a holding company that operates seven distinct business. Operations Group Baring Private Equity. Darek Lenart – Senior VP HR, Finance MasterCard. Former HR director with Pepsi Central Eastern Europe, and gained HR expertise at PLIVA Pharmaceutical Company (now part of Teva Group). Former CEOs / Advisors.

Executive Coaching 70

Executive Coaching CEO Banking Magazine 70

Harvard Business Review

JUNE 20, 2017

Multinational companies operating in Mexico are facing a great deal of uncertainty. Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards.

Supply Chain 12

Supply Chain Depreciation Uncertainty Marketing 12

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain 13

Supply Chain Products Productivity Company 13

Harvard Business Review

AUGUST 23, 2016

Boards of companies operating in the consumer discretionary industry have a disproportionately high representation of Democrats, while boards operating in the industrials and energy and utilities industries skew more Republican. Both Republicans and Democrats say the most effective board committee is audit/finance.

Politics 8

Politics Committee Telecommunications Diversity 8